Foley Hoag, LLP
Patent reexamination counsel·4 ex parte reexams
Foley Hoag, LLP has served as patent-owner counsel in 4 USPTO ex parte reexaminations. The firm most often represents Lennham Pharmaceuticals Inc., AbbVie Inc., and Artemis Biosystems Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Outcome track record
How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.
- Certificate outcome split across every bucket
- Share of proceedings where claims survived
Practice metrics
Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.
- Certificate rate of closed proceedings
- Average pendency in months
Examiners & adversaries
Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.
- Most frequent examiners
- Top opposing requesters
Recent reexaminations (4)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/014,868 | Sep 23, 2021 | 11,000,534 | DEUTERATED DERIVATIVES OF PSILOCYBIN AND USES THEREOF | Lennham Pharmaceuticals Inc. | Closed |
| 90/014,436 | Jan 18, 2020 | 9,163,017 | ANTI-VIRAL COMPOUNDS | AbbVie Inc. | Closed |
| 90/014,409 | Nov 12, 2019 | 10,358,626 | PERFUSION FILTRATION SYSTEMS | Artemis Biosystems Inc. | Closed |
| 90/020,024 | Sep 14, 2012 | 6,100,526 | GRAIN QUALITY MONITOR | Dsquared Development Inc. | Closed |
Other reexam law firms
See the full reexam picture for Foley Hoag, LLP
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.